Overall Management > Germ Cell Tumors


Journal of Neuro-Oncology, 68 (2): 153-159, June 2004. (Clinical Study)


Abstract

Intracranial Germ Cell Tumors: A Single Institution Experience and Review of the Literature

A.A. Smith, E. Weng, M. Handler, N.K. Foreman

Department of Pediatric Oncology, The Children's Hospital (A.A.S.); Department of Radiation Therapy (E.W.), Department of Neurosurgery (M.H.), Department of Pediatrics (N.K.F.), Division of Pediatric Oncology, University of Colorado Health Sciences Center; Denver, CO, USA

There is little literature to guide therapy in children and young adults with intracranial germ cell tumors. 
We present 17 consecutively diagnosed intracranial germ cell tumors at The Children's Hospital, Denver, from 1995 to 2001. 
Of 17 patients, 3 had considerable delay in diagnosis. 
Two with suprasellar tumors presented with dementia, blindness and pan-hypopituitarism and another with recurrent subarachnoid hemorrhage. 
Seven had germinoma, three were metastatic at diagnosis. 
Ten had non-germinomatous germ cell tumors (NGGCT), 5/10 were alpha feto-protein (AFP) positive only, one
β-human chorionic growth (βHCG) factor positive only, 3 positive for AFP and βHCG, and 1 malignant teratoma. 
Therapy for metastatic patients consisted of chemotherapy followed by craniospinal radiation (CSI). 
Patients with localized disease received chemotherapy followed by focal radiation. 
Two patients received chemotherapy only, one because she died of sepsis while receiving chemotherapy and one because of neurologic injury incurred during surgery parents elected for no therapy. 
Three patients have died, one of tumor recurrence, one from a remote complication of surgery and one of sepsis. 
Twelve patients are alive without evidence of disease from 10 to 68 months (median 31.5 months). 
All five children with only AFP positivity, treated with chemotherapy and focal radiation are alive without evidence of disease at 10, 16, 22, 41 and 41 months. 
Thus, there is little evidence that CSI is necessary in non-metastatic germinomas and AFP positive NGGCTs when combined chemotherapy and radiation therapy is used. 
However, complications of delayed diagnosis, surgery and chemotherapy are important causes of mortality, with only one patient dying of tumor.

Keywords: chemotherapy, germinoma, intracranial, non-germinomatous germ cell tumor, radiation

Copyright © 2004 Kluwer Academic Publishers. All rights reserved

Source: http://journals.kluweronline.com/article.asp?PIPS=5138410



 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP